Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain Management | 16 | 2026 | 194 | 3.200 |
Why?
|
| Chronic Pain | 9 | 2025 | 203 | 2.230 |
Why?
|
| Spinal Cord Stimulation | 5 | 2025 | 20 | 1.770 |
Why?
|
| Analgesics | 5 | 2021 | 131 | 1.420 |
Why?
|
| Kyphoplasty | 2 | 2022 | 7 | 1.360 |
Why?
|
| Fractures, Compression | 2 | 2022 | 22 | 1.330 |
Why?
|
| Education, Medical, Graduate | 5 | 2024 | 448 | 1.270 |
Why?
|
| Spinal Fractures | 2 | 2022 | 103 | 1.240 |
Why?
|
| Analgesia, Epidural | 3 | 2019 | 42 | 1.230 |
Why?
|
| Osteoarthritis, Knee | 5 | 2026 | 86 | 1.030 |
Why?
|
| Perioperative Care | 6 | 2022 | 198 | 1.000 |
Why?
|
| Stellate Ganglion | 1 | 2026 | 4 | 0.950 |
Why?
|
| Autonomic Nerve Block | 1 | 2026 | 7 | 0.950 |
Why?
|
| Analgesics, Opioid | 7 | 2026 | 539 | 0.910 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 342 | 0.890 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 338 | 0.890 |
Why?
|
| Embolization, Therapeutic | 5 | 2026 | 319 | 0.880 |
Why?
|
| Pandemics | 3 | 2020 | 915 | 0.850 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2026 | 133 | 0.810 |
Why?
|
| Military Personnel | 1 | 2026 | 119 | 0.810 |
Why?
|
| Equipment Failure | 2 | 2016 | 119 | 0.810 |
Why?
|
| Fellowships and Scholarships | 5 | 2024 | 164 | 0.790 |
Why?
|
| Vertebroplasty | 1 | 2022 | 16 | 0.720 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2022 | 26 | 0.700 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 200 | 0.630 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2019 | 3 | 0.600 |
Why?
|
| Pain | 6 | 2023 | 416 | 0.590 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 157 | 0.580 |
Why?
|
| Orthopedics | 1 | 2021 | 140 | 0.580 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 40 | 0.580 |
Why?
|
| Osteoporotic Fractures | 1 | 2020 | 57 | 0.580 |
Why?
|
| Foreign-Body Migration | 1 | 2019 | 32 | 0.580 |
Why?
|
| Catheters | 1 | 2019 | 109 | 0.550 |
Why?
|
| Artifacts | 1 | 2019 | 248 | 0.520 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 170 | 0.520 |
Why?
|
| Anesthesia | 2 | 2022 | 174 | 0.510 |
Why?
|
| Humans | 45 | 2026 | 97913 | 0.500 |
Why?
|
| Treatment Outcome | 14 | 2026 | 9689 | 0.490 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2016 | 2 | 0.480 |
Why?
|
| Cancer Pain | 2 | 2026 | 6 | 0.470 |
Why?
|
| Internal-External Control | 1 | 2016 | 47 | 0.470 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 127 | 0.450 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 254 | 0.440 |
Why?
|
| Polyethylene Glycols | 2 | 2025 | 382 | 0.390 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2014 | 82 | 0.390 |
Why?
|
| Radiography, Interventional | 2 | 2026 | 157 | 0.370 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2012 | 6 | 0.360 |
Why?
|
| Dexmedetomidine | 1 | 2012 | 19 | 0.350 |
Why?
|
| Pleura | 1 | 2012 | 31 | 0.350 |
Why?
|
| Mentors | 2 | 2025 | 101 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3605 | 0.350 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 53 | 0.350 |
Why?
|
| Ketamine | 1 | 2011 | 30 | 0.340 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 102 | 0.340 |
Why?
|
| Depression | 1 | 2016 | 614 | 0.330 |
Why?
|
| Pharmacogenetics | 4 | 2022 | 472 | 0.330 |
Why?
|
| Colectomy | 1 | 2012 | 200 | 0.320 |
Why?
|
| Ambulatory Care | 1 | 2011 | 201 | 0.310 |
Why?
|
| Pharmacogenomic Testing | 2 | 2021 | 119 | 0.300 |
Why?
|
| Spinal Cord | 3 | 2023 | 244 | 0.280 |
Why?
|
| Anesthesiology | 2 | 2022 | 171 | 0.280 |
Why?
|
| Telemedicine | 2 | 2021 | 249 | 0.260 |
Why?
|
| Betacoronavirus | 2 | 2020 | 287 | 0.250 |
Why?
|
| Knee Joint | 2 | 2026 | 177 | 0.250 |
Why?
|
| Cluster Headache | 1 | 2025 | 3 | 0.230 |
Why?
|
| Sacroiliac Joint | 1 | 2025 | 13 | 0.230 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2025 | 12 | 0.230 |
Why?
|
| Arthralgia | 1 | 2025 | 44 | 0.230 |
Why?
|
| Buprenorphine | 1 | 2026 | 57 | 0.230 |
Why?
|
| Anesthetics, Local | 2 | 2018 | 85 | 0.230 |
Why?
|
| Back Pain | 1 | 2025 | 76 | 0.220 |
Why?
|
| Prospective Studies | 5 | 2022 | 4815 | 0.220 |
Why?
|
| United States | 4 | 2024 | 8155 | 0.210 |
Why?
|
| Mentoring | 1 | 2025 | 39 | 0.210 |
Why?
|
| Quality of Life | 3 | 2023 | 1892 | 0.200 |
Why?
|
| Career Choice | 1 | 2025 | 161 | 0.190 |
Why?
|
| Middle Aged | 9 | 2025 | 29366 | 0.190 |
Why?
|
| Electric Injuries | 1 | 2022 | 19 | 0.180 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2025 | 416 | 0.180 |
Why?
|
| Injections, Spinal | 1 | 2022 | 49 | 0.180 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2021 | 10 | 0.170 |
Why?
|
| Drug Hypersensitivity | 1 | 2021 | 38 | 0.170 |
Why?
|
| Female | 14 | 2025 | 51441 | 0.170 |
Why?
|
| Postoperative Period | 2 | 2019 | 322 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2025 | 421 | 0.170 |
Why?
|
| Pharmacogenomic Variants | 1 | 2021 | 46 | 0.170 |
Why?
|
| Anesthetics | 1 | 2021 | 51 | 0.170 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 412 | 0.170 |
Why?
|
| Male | 13 | 2025 | 46983 | 0.160 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 62 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2021 | 175 | 0.150 |
Why?
|
| Neoplasms | 2 | 2026 | 3325 | 0.150 |
Why?
|
| Workflow | 1 | 2020 | 85 | 0.150 |
Why?
|
| Extremities | 1 | 2021 | 171 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2023 | 335 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2020 | 86 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 194 | 0.150 |
Why?
|
| Nociception | 1 | 2019 | 8 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 3014 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2025 | 10922 | 0.150 |
Why?
|
| Thoracotomy | 1 | 2019 | 71 | 0.140 |
Why?
|
| Femoral Nerve | 1 | 2018 | 9 | 0.140 |
Why?
|
| Median Arcuate Ligament Syndrome | 1 | 2018 | 23 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 132 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 657 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 258 | 0.130 |
Why?
|
| Nerve Block | 1 | 2018 | 55 | 0.130 |
Why?
|
| Consensus | 3 | 2025 | 314 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 166 | 0.120 |
Why?
|
| Bupivacaine | 2 | 2018 | 48 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 117 | 0.120 |
Why?
|
| Contrast Media | 1 | 2021 | 1011 | 0.120 |
Why?
|
| Comorbidity | 2 | 2018 | 1031 | 0.120 |
Why?
|
| Aged | 6 | 2025 | 21703 | 0.110 |
Why?
|
| Microspheres | 2 | 2025 | 91 | 0.110 |
Why?
|
| Critical Care | 1 | 2019 | 481 | 0.110 |
Why?
|
| Pain Measurement | 3 | 2025 | 401 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1946 | 0.110 |
Why?
|
| Adolescent | 3 | 2020 | 10078 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2033 | 0.100 |
Why?
|
| Capsaicin | 1 | 2013 | 43 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 80 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2018 | 483 | 0.100 |
Why?
|
| Delphi Technique | 2 | 2025 | 180 | 0.090 |
Why?
|
| Arachnoiditis | 1 | 2012 | 2 | 0.090 |
Why?
|
| Clonidine | 1 | 2012 | 33 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 24 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 44 | 0.090 |
Why?
|
| Infant | 1 | 2019 | 3325 | 0.090 |
Why?
|
| Dura Mater | 1 | 2012 | 47 | 0.090 |
Why?
|
| Neural Tube Defects | 1 | 2012 | 39 | 0.090 |
Why?
|
| Propofol | 1 | 2012 | 95 | 0.090 |
Why?
|
| Young Adult | 3 | 2018 | 7490 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 255 | 0.090 |
Why?
|
| Cicatrix | 1 | 2012 | 79 | 0.080 |
Why?
|
| Delirium | 1 | 2012 | 82 | 0.080 |
Why?
|
| Morphine | 1 | 2012 | 127 | 0.080 |
Why?
|
| Risk Factors | 4 | 2026 | 6220 | 0.080 |
Why?
|
| Adult | 5 | 2025 | 29498 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 2440 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2026 | 1108 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 3267 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 477 | 0.070 |
Why?
|
| Time Factors | 2 | 2018 | 5566 | 0.060 |
Why?
|
| Emulsions | 1 | 2025 | 20 | 0.060 |
Why?
|
| Prognosis | 2 | 2025 | 4105 | 0.060 |
Why?
|
| PubMed | 1 | 2024 | 16 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 75 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 77 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 2582 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2023 | 107 | 0.050 |
Why?
|
| Arteries | 1 | 2023 | 171 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Succinylcholine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 22 | 0.050 |
Why?
|
| Perfusion | 1 | 2023 | 271 | 0.040 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 290 | 0.040 |
Why?
|
| Mastectomy | 1 | 2023 | 271 | 0.040 |
Why?
|
| Executive Function | 1 | 2022 | 114 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2676 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 1130 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 1750 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 568 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 304 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 155 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 176 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 164 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2018 | 148 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 670 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 839 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2785 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 219 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 469 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1002 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2024 | 1123 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 875 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 684 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1778 | 0.030 |
Why?
|